Administration of anti-CD73 regent increases tumor cell death in vitro, and CD73 blockade exhibits slower tumor outgrowth and significantly increased antigen-specific CD8+ T-cell immunogenicity following treatment with pemetrexed in an EGFR-mutant lung cancer mouse model [30,102]. The gene discussed is EGFR; the disease is neoplasm.